Top of this page
Skip navigation, go straight to the content

Newsroom Overview

Newsroom

Press Release

UCB and Amgen Receive Positive Vote From FDA Advisory Committee In Favor of Approval For EVENITY™ (Romosozumab) 16 Jan 2019

UCB and Amgen Receive Positive Vote From FDA Advisory Committee …

Read more
EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture08 Jan 2019

EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of …

Read more
Transparency notification UCB SA/NV08 Jan 2019

Transparency notification UCB SA/NV

Read more

UCB Stories

Picture of teamwork 20 Dec 2018

90 years of innovation, adaptation and progress

Read more
general picutre of neurology content 3 Dec 2018

Starting from a patient perspective focuses epilepsy treatment progress …

Read more
picture of green strategy 26 Nov 2018

Making our packaging ‘greener’

Read more

Social Media